Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Non-Current Assets (2020 - 2025)

GeneDx Holdings (WGS) has disclosed Non-Current Assets for 6 consecutive years, with $255.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Non-Current Assets changed N/A to $255.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $515.6 million, a N/A change, with the full-year FY2025 number at $255.4 million, changed N/A from a year prior.
  • Non-Current Assets was $255.4 million for Q4 2025 at GeneDx Holdings, down from $259.0 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $530.6 million in Q2 2022 to a low of -$225.8 million in Q1 2025.
  • A 5-year average of $205.5 million and a median of $236.4 million in 2023 define the central range for Non-Current Assets.
  • Peak YoY movement for Non-Current Assets: soared 705.55% in 2022, then plummeted 197.71% in 2025.
  • GeneDx Holdings' Non-Current Assets stood at $70.5 million in 2021, then surged by 294.51% to $278.3 million in 2022, then fell by 15.06% to $236.4 million in 2023, then decreased by 4.01% to $226.9 million in 2024, then increased by 12.55% to $255.4 million in 2025.
  • Per Business Quant, the three most recent readings for WGS's Non-Current Assets are $255.4 million (Q4 2025), $259.0 million (Q2 2025), and -$225.8 million (Q1 2025).